Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary
- PMID: 23184039
- DOI: 10.1007/s00134-012-2758-y
Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary
Abstract
Introduction: Alcohol withdrawal is common among intensive care unit (ICU) patients, but no current practice guidelines exist. We reviewed published manuscripts for prevalence, risk factors, screening tools, prophylactic and treatment strategies, and outcomes for alcohol withdrawal syndrome (AWS) and delirium tremens (DT) in the critically ill.
Methods: The following databases: PubMed, MEDLINE, Embase, Cochrane Database of Systematic Reviews and Central Register of Controlled Trials, CINAHL, Scopus, Web of Knowledge, pain, anxiety and delirium (PAD) Guidelines REFWORKS, International Pharmaceutical Abstracts and references for published papers were searched. Publications with high or moderate Grading of Recommendations Assessment, Development and Evaluation (GRADE) and Oxford levels of evidence were included.
Results: Reported AWS rates range from <1 % in 'all ICU comers' to 60 % in highly selected alcohol-dependent ICU patients. Alcohol dependence and a history of withdrawal are significant risk factors for AWS occurrence. No screening tools for withdrawal have been validated in the ICU. The benefit of alcohol withdrawal prophylaxis is unproven, and proposed regimens appear equivalent. Early and aggressive titration of medication guided by symptoms is the only feature associated with improved treatment outcome.
Conclusions: Treatment of AWS is associated with higher ICU complication rates and resource utilization. The optimal means of identification, prevention and treatment of AWS in order to establish evidence-based guidelines remain to be determined.
Similar articles
-
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.Alcohol. 2014 Jun;48(4):375-90. doi: 10.1016/j.alcohol.2014.01.004. Epub 2014 Feb 19. Alcohol. 2014. PMID: 24657098
-
Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials.Alcohol Clin Exp Res. 2013 Apr;37(4):675-86. doi: 10.1111/acer.12002. Epub 2012 Nov 26. Alcohol Clin Exp Res. 2013. PMID: 23550610
-
The effectiveness of interventions to meet family needs of critically ill patients in an adult intensive care unit: a systematic review update.JBI Database System Rev Implement Rep. 2016 Mar;14(3):181-234. doi: 10.11124/JBISRIR-2016-2477. JBI Database System Rev Implement Rep. 2016. PMID: 27532144
-
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2. Cochrane Database Syst Rev. 2016. PMID: 27699783 Free PMC article.
-
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2. Cochrane Database Syst Rev. 2021. PMID: 34280303 Free PMC article.
Cited by
-
Alcohol withdrawal is associated with poorer outcome in acute ischemic stroke.Neurology. 2019 Nov 19;93(21):e1944-e1954. doi: 10.1212/WNL.0000000000008518. Epub 2019 Oct 25. Neurology. 2019. PMID: 31653706 Free PMC article.
-
Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study.Ann Intensive Care. 2015 Dec;5(1):33. doi: 10.1186/s13613-015-0075-7. Epub 2015 Nov 2. Ann Intensive Care. 2015. PMID: 26525052 Free PMC article.
-
Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.PLoS One. 2021 Dec 20;16(12):e0261443. doi: 10.1371/journal.pone.0261443. eCollection 2021. PLoS One. 2021. PMID: 34928984 Free PMC article.
-
Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome.Neuropsychopharmacol Rep. 2023 Dec;43(4):532-541. doi: 10.1002/npr2.12347. Epub 2023 Jun 27. Neuropsychopharmacol Rep. 2023. PMID: 37368937 Free PMC article.
-
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?J Med Toxicol. 2014 Dec;10(4):369-81. doi: 10.1007/s13181-014-0430-3. J Med Toxicol. 2014. PMID: 25238670 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical